A plateau is three or more consecutive weeks with no downward trend — not a flat week or a two-pound fluctuation. The three fixable causes, in order: you are still below a therapeutic dose, lost muscle has lowered your energy expenditure, or portions have crept back as appetite suppression normalized.
On this page
Confirm it is actually a plateau
Weight fluctuates by several pounds daily on hydration, sodium, glycogen and menstrual cycle. Judge by a weekly average across at least three weeks, weighed at the same time of day under the same conditions. Take waist measurements too — body composition can improve while the scale sits still.
Check you are on a treatment dose
2.5 mg is not a treatment dose. 5 mg is the first one. If you have been sitting at a low dose for months because escalation felt intimidating or because your program raises the price at each tier, that is the first thing to fix. Most people find their working dose between 7.5 mg and 12.5 mg.
Protect muscle
Up to about 40% of weight lost during rapid loss can be lean mass without deliberate intervention, and less muscle means lower resting energy expenditure — a plateau you built yourself. Adequate protein (commonly cited as roughly 1.2 g per kg of body weight daily) and resistance training two to three times weekly are the evidence-backed levers. Discuss specific targets with your clinician or a dietitian.
Reassess intake honestly
As your body adapts, appetite suppression softens. Three days of accurate logging usually reveals the drift. This is not a failure of willpower — it is the predictable pharmacology of adaptation.
When switching molecules is the right answer
If you are on maximum tolerated semaglutide with an inadequate response, SURMOUNT-5 supports switching to tirzepatide. If you are already at 15 mg tirzepatide and truly plateaued, the conversation moves to combination approaches, evaluation for secondary causes, or accepting a new maintenance set point.
Common questions
Why is some tirzepatide advertised under $100 a month?
Usually one of four reasons: it is the 2.5 mg starter-tier price only, it is an introductory rate that reverts, there is a separate membership fee, or the product is not from a licensed US pharmacy. Ask what you will pay at 10 mg before you enrol.
What is the difference between a 503A and a 503B pharmacy?
A 503A pharmacy compounds for an identified individual patient with a prescription and is licensed by a state board of pharmacy. A 503B outsourcing facility registers with FDA, may compound in bulk without patient-specific prescriptions, and is subject to current good manufacturing practice requirements. Most compounded tirzepatide now flows through the 503A pathway.
How much does tirzepatide cost per month without insurance?
Compounded tirzepatide from licensed US telehealth programs runs roughly $99 to $299 per month depending on the provider and whether the price is flat or scales with your dose. Brand-name Zepbound through LillyDirect self-pay runs about $299 to $449 per month depending on strength. Retail Zepbound without any program is around $1,089.
Is compounded tirzepatide the same as Zepbound?
The active ingredient is the same molecule. Zepbound is FDA-approved, manufactured by Eli Lilly and reviewed by FDA for safety, effectiveness and quality. Compounded tirzepatide is prepared by a state-licensed pharmacy for an individual patient and is not FDA-approved or FDA-reviewed. The pharmacology is identical; the quality assurance structure is not.
People also ask about tirzepatide plateau
What is tirzepatide plateau?
Tirzepatide plateau is covered in full on this page, with the clinical detail drawn from the tirzepatide prescribing information and the published SURMOUNT and SURPASS trial program, and any price figures drawn from our tracked dataset and dated to their last verification.
Does tirzepatide plateau apply to compounded tirzepatide as well as Zepbound?
The molecule is the same, so the clinical content applies to both. What differs is regulatory status, dose metering and price: compounded preparations are not FDA-approved, arrive as a multi-dose vial you measure yourself, and cost a fraction of the brand routes.
How much does tirzepatide plateau cost per month in 2026?
Compounded tirzepatide runs from $133 per month at the entry dose across the 21 compounded programs we track. At a 10 mg maintenance dose the cheapest tracked route is Oak Longevity at $199 per month, or about $2,388 for a first year on the standard escalation. Brand Zepbound through manufacturer self-pay sits well above that and pharmacy retail well above again. Verified 2026-08-05.
Is tirzepatide plateau FDA-approved?
Brand tirzepatide (Zepbound and Mounjaro) is FDA-approved. Compounded tirzepatide is not: FDA does not approve compounded drugs and does not review them for safety, effectiveness or quality before they are marketed. The active molecule is the same; the regulatory review is not.
Primary sources
Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.
- ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
- FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
- Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
- The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.